Women's Health

blog image
Women's Health

Study finds that most still recommend the breast cancer screen for women in their early 40s

Read more

Zejula Approved for Certain Female Cancers

TUESDAY, March 28, 2017 -- Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurring cancers of the ovaries, fallopian tubes or abdominal wall (peritoneum) whose tumors have shrunk in response to platinum-based chemotherapy.

Citing the National Cancer Institute, the FDA said in a news release that more than 22,000 women are expected to be diagnosed with these cancers this year, and more than 14,000 will die of these diseases.

Read more
blog image
Women's Health

While a few extra pounds doesn't up death risk, weight around the middle does, study contends

Read more
blog image
Women's Health

But embolization might not be suitable for every woman, specialist says

Read more